Advertisement
Nordic Life Sience NO 04
Published: November 13, 2020
Advertisement
Advertisement
Published: November 13, 2020
Advertisement
Advertisement
Top stories
Biotech Business – January 22, 2025
The South Korean Patent Office will grant a patent protecting the use of insulin-based antigens for the treatment of autoimmune diabetes in patients with the HLA DR4-DQ8 genetic marker.
Global report – January 21, 2025
President Donald Trump announced on Monday January 20 that the United States will leave the World Health Organization (WHO).
Denmark – January 21, 2025
CSL Behring Denmark has announced that the first Danish patients with haemophilia B were treated with the gene therapy HEMGENIX (etranacogene dezaparvovec).
New Market – January 20, 2025
First approval in the US for AstraZeneca and Daiichi Sankyo’s Datroway based on TROPION-Breast01 results showing 37% reduction in the risk of disease progression or death vs. chemotherapy.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Related posts
This site uses cookies